The ability of normal rabbit dermal fibroblasts to degrade films of type IV collagen and gelatin when stimulated by phorbol ester was shown to be dependent on the induction, secretion and activation of 95 kDa gelatinase B and the secretion and activation of 72 kDa gelatinase A and stromelysin. Degradation was inhibited by exogenous human recombinant tissue inhibitor of metalloproteinases-1, specific antibodies to gelatinase and stromelysin and by the reactiveoxygen-metabolite inhibitor catalase. We discuss the various pathways for activation of matrix metalloproteinases in this model system and conclude that, although plasmin may play a key role in the activation of gelatinase B and stromelysin, gelatinase A is activated by a mechanism which has yet to be elucidated. The involvement of oxygen radicals in the direct activation of matrix metalloproteinases in this model is thought to be unlikely.
INTRODUCTION
Cell migration in tissue remodelling and embryonic development, and in pathological conditions such as the arthritides and tumour metastasis, requires invasion and degradation of extracellular matrices and basement membranes. The matrix metalloproteinases (MMPs), secreted as latent zymogens by connective-tissue cells, are thought to be important effectors of these degradative processes. This family of proteinases includes the well-characterized enzymes interstitial collagenase, stromelysin and two gelatinases (reviewed by Docherty & Murphy, 1990) , which together are capable of degrading all the components of the extracellular matrix. Of these proteinases, the gelatinases and stromelysin, whose substrates include type IV collagen and denatured collagens, are those most likely to be involved in the degradation of basement membranes. The two gelatinases are a 72 kDa species, gelatinase A (also known as type IV collagenase or MMP-2) and a 95 kDa enzyme, gelatinase B (MMP-9), which was originally described in neutrophils (Sopata & Dancewicz, 1974) . Both gelatinases are secreted as proforms by a wide range ofnormal and malignant connective-tissue cells. Like collagenase and stromelysin, gelatinase B is phorbolester-inducible in several cell types (Ballin et al., 1988; Moll et al., 1990; Hipps et al., 1991) . The secretion of both gelatinase A and gelatinase B has been associated with increased metastatic potential (Garbisa et al., 1987; Tryggvason et al., 1987; Yamagata et al., 1989) .
The activation mechanisms of the MMPs involve complex proteolytic cascades with plasmin (Eeckhout & Vaes, 1977; Werb et al., 1977) , other MMPs and autoactivation (Stetler-Stevenson et al., 1989) . In many resorbing systems the actions of the MMPs are limited by the tissue inhibitors of MMPs, tissue inhibitor of metalloproteinases-I (TIMP-1) and TIMP-2 (Murphy et al., 1981a; Docherty & Murphy, 1990; Ward et al., 1991a) , which are co-secreted by numerous cell types. Activation of the gelatinases in vitro can be accomplished by mercurial compounds via conformational change and self-cleavage, but physiological activators have yet to be clearly established. Unlike the other MMPs, the gelatinases (especially gelatinase A) are not efficiently activated by either trypsin or plasmin (Okada et al., 1990) . A cell-membraneassociated activator of progelatinase A has recently been demonstrated in human fibroblast monolayers stimulated with concanavalin A (Brown et al., 1990; Overall & Sodek, 1990; Ward et al., 1991b) . Additionally, Peppin & Weiss (1986) reported the activation of neutrophil gelatinase by an HOCl-dependent pathway, and Vissers & Winterbourn (1988) have demonstrated a possible role for elastase in the activation of this enzyme.
Type IV collagen is a major structural component of the basement membrane, and we report here the use of a model system to study its degradation by stimulated normal rabbit skin fibroblasts. We demonstrate that TIMP-1, specific antibodies to gelatinase and stromelysin, and the reactive-oxygen-metabolite inhibitor catalase, are all capable of inhibiting this process. These and previous data suggest multiple pathways for the activation of the gelatinases and the potential involvement of gelatinase and stromelysin in basement-membrane degradation.
MATERIALS AND METHODS
Type IV collagen (gift from Professor Klaus Kuhn, Max Planck Institut fur Biochemie, Martinsried, Germany) was extracted from the Engelbreth-Holm-Swarm murine tumour by the method of Kleinman et al. (1982) . Pig polymorphonuclear leucocyte (PMNL) gelatinase B was prepared as described by Murphy et al. (1989b) , and gelatinase A was purified from human gingival fibroblast conditioned medium (Hipps et al., 199 1). Recombinant human stromelysin and recombinant human TIMP-1 were generously donated by Peter Koklitis and Saroj Angal, Celltech Ltd., Slough, Berks., U.K.
Anti-stromelysin IgG was prepared from an (NH4)2SO4 precipitation of antiserum to rabbit stromelysin raised in sheep (Murphy et al., 1986) . The IgG was purified by binding to a Protein G-Sepharose column according to the manufacturer's (Pharmacia LKB) instructions and elution at pH 2.7. Antigelatinase IgG, which recognizes both gelatinases, was purified in a similar way from an antiserum to rabbit gelatinase (Murphy et al., 1989a parison) was also purified using Protein G-Sepharose, and all three IgG preparations were dialysed against Dulbecco's modification of Eagle's medium (DMEM) and filter-sterilized before use.
1251I-labelled Bolton and Hunter reagent was from Amersham International, and bacterial collagenase and Dispase were from Boehringer, Mannheim, Germany. Catalase (cell-culture grade), superoxide dismutase (SOD), phorbol 12-myristate 13-acetate (PMA), 4-aminophenylmercuric acetate (APMA), aprotinin, a2-antiplasmin and soya-bean trypsin inhibitor were all from Sigma. Anti-(human tissue-type plasminogen activator) antiserum was from Bioscot, Edinburgh, Scotland, U.K., and anti-(human urokinase) antiserum was from American Diagnostica, New York, NY, U.S.A.
Rabbit dermal fibroblasts
Rabbit dermal fibroblasts were prepared by the enzymic digestion of 3 cm2 pieces of skin dissected from the abdomen of newborn New Zealand White rabbits. Briefly, the skin was cut into 1 mm2 pieces and washed for 10 min in dissecting medium, a modified Biggers, Gwatkin & Judah (BGJ) medium (Reynolds, 1976) . The tissue was digested at 37°C with gentle stirring for 30 min in Dispase (2 mg/ml in DMEM). The supernatant was discarded, and the skin was digested for a further 45 min in bacterial collagenase (4 mg/ml in DMEM). This supernatant was also discarded, and the remaining skin fragments were washed twice in DMEM, agitating with a Pasteur pipette. The cells released during these washes were recovered by centrifugation at 300 g, resuspended in DMEM containing 10 % fetalcalf serum (FCS) and plated into two 75 cm2 culture flasks. The cells were grown to confluence and subcultured several times before use; usually fourth to seventh passage cells were used for the experiments.
Type IV collagen films Radiolabelled type IV collagen films were prepared by diluting 125I-labelled type IV collagen (approx. 7.5 x 107 c.p.m./mg; Bolton & Hunter 1973) with unlabelled collagen. The collagen was dialysed into 10 mM-phosphate buffer, pH 6.8, containing 300 mM-NaCl and 0.02 % NaN3; labelled and unlabelled collagen were mixed to give 20,ug in 100,l for each well of 96-well microtitre plates (1.5 x 104 c.p.m./well). The films were dried on to the culture wells at 37°C over 2-3 days, then washed overnight with sterile distilled water. After a further water wash and two washes with DMEM the cells were seeded on to the films at 2 x 104 cells/well in DMEM with 10% FCS and allowed to attach overnight. After 24 h the cells were gently washed twice with serum-free DMEM and then 200 pl of DMEM was added to each well, with or without the test substances. After incubation for 48 or 72 h the media were collected and counted in a yradiation counter and subsequently retained for enzyme assays and zymograms. In those experiments where inhibitors had been added during the initial incubation, the cells were incubated for a further 48 h or 72 h to assess recovery after removal of the inhibitors. The remaining undegraded collagen in the wells was digested by adding 100 ,ug of trypsin/ml and incubating at 37°C overnight followed by y-radiation counting to estimate the total radioactivity in each well. The percentage release of 125I from the films under various conditions was calculated from these data.
Gelatin films 14C-labelled gelatin films were prepared from denatured rat skin type I collagen using a modification of the method described by Gavrilovic et al. (1985) . 14C-labelled type I collagen prepared from rat skins at a concentration of 1 mg/ml in 10 mM-phosphate buffer (as described above) was denatured by heating for 20 min in a water bath at 60 'C. After denaturation it was diluted to a concentration of 0.5 mg/ml using an equal volume of phosphate buffer (as described above) and dispensed into 24-well Linbro culture dishes at 300 ,ul/well (150 ,ug of gelatin; 10000 d.p.m.).
The films were allowed to dry by incubating at 37 'C for 3-4 days. Gelatin was cross-linked by adding 300 z1l of 2% glutaraldehyde in phosphate-buffered saline (Dulbecco 'A', pH 7.3) and shaking at room temperature for 10 min. An equal volume of 0.1 M-glycine was added to each well for a further 5 min, then the media were removed and discarded and the wells washed three times with 10 mM-phosphate buffer (as described above). The films were washed overnight with 500 jul of sterile distilled water, followed by a further water wash for 3 h and two washes with DMEM before use.
Cells were plated in DMEM with 10 % FCS at a density of 105 cells/well and allowed to attach overnight. After 24 h the cells were gently washed twice with DMEM, then 500 ,t1 of DMEM with or without the test substances were added to each. After incubation for 48 or 72 h at 37 'C the media were removed, centrifuged (10000g; 15 min) and 10Ojul aliquots taken for liquid-scintillation counting. The remaining media were retained for enzyme assays and zymograms, and the undegraded gelatin left in the wells digested overnight using 500 jul of DMEM containing trypsin (100 ug/ml) and counting radioactivity as described above. Percentage radioactivity released during the test period was calculated from the total radioactivity obtained from both incubations.
Enzyme and inhibitor assays
Assays for gelatinase and stromelysin activities in the cell supernatants were performed as described by Murphy et al. (1981b) . One unit of enzyme degrades 1 jug of substrate in 1 min at 37 'C. Enzyme levels were measured in either the presence or absence of 0.7 mM-APMA.
TIMP was assayed by the inhibition of activated rabbit collagenase; 1 unit of TIMP inhibits 2 units of collagenase by 50 % (Murphy et al., 1977) .
Zymogram analysis of cell supernatants
Samples of cell supernatants were run on either 7 or 8 % (w/v) polyacrylamide/SDS gels by the method of Laemmli & Fav-re (1973) , but with 0.5 mg/ml of denatured type I collagen incorporated into the gel (Heussen & Dowdle, 1980) . Staining with Coomassie Brilliant Blue revealed zones of lysis indicating gelatin-degrading activity.
RESULTS

Film degradation
The efficacy and reproducibility of using type IV collagen and gelatin films in our model system of matrix degradation were tested initially using purified active pig PMNL gelatinase B, human fibroblast gelatinase A and recombinant human stromelysin. Typical results with type IV collagen are illustrated in Fig. 1 . Each of the three enzymes degraded the films by more than 70 % in a dose-dependent manner, and the gelatinases were two or more orders of magnitude more potent than stromelysin. This reduced potency cannot be accounted for by the trypsinactivation procedure (see the legend to Fig. 1 Rabbit dermal fibroblasts degraded both types of film by more than 50 % when incubated with PMA (10 ng/ml) in serum-free DMEM. Results with type IV collagen are shown in Table 1 . Untreated cells gave only 5-15 % lysis of the films.
Inhibition of film degradation 1251 release from the films was inhibited by including human recombinant TIMP-1 with the PMA-stimulated cells cultured on type IV collagen (Table la) , but more than 60% degradation occurred after its removal and further stimulation with PMA (Table lb) . Lysis of type IV collagen films was inhibited by adding specific antibodies to gelatinase and stromelysin along with the PMA. Each antibody used alone only partially inhibited degradation (results not shown), but a combination of the two gave considerable inhibition when compared with normal sheep serum IgG (Table la) . The cells recovered their ability to degrade the films after removal of the antibodies and re-stimulation with PMA (Table lb) .
Inhibition of degradation was also achieved when catalase, which catalyses hydrogen peroxide degradation, was added at the same time as the PMA (Table la) . A lesser inhibition was also found with methionine, a scavenger of chlorinated oxidants, but other reactive-oxygen-metabolite scavengers such as SOD and NaN3, which blocks myeloperoxidase activity, had no effect on this system. Neither catalase nor NaN3 used at these concentrations had any effect on cell viability, as assessed by Trypan Blue exclusion. The catalase inhibitory effect was overcome when catalase was removed and a further dose of PMA was administered (Table Ib) . Catalase which had been heat-inactivated by boiling for 15 min had no inhibitory activity when cells were incubated with or without PMA on ['4C]gelatin films (Table 2) .
Little inhibition of degradation was seen when serine-proteinase inhibitors were included in the cultures at the same time Table 1 . Inhibition of type IV collagen degradation by PMA-stimulated rabbit dermal fibroblasts using TIMP-1 antibodies to gelatinase and stromelysin and reactive-oxygen-metabolite inhibitors Experimental procedures were as described in the text. (a) Percentage lysis of '25I-labelled type IV collagen after 72 h at 37°C with or without PMA (10 ng/ml), TIMP-l (10 units/ml), normal sheep serum IgG (500 ,sg/ml), anti-gelatinase IgG (200 ,ug/ml), antistromelysin IgG (300 ,ug/ml), L-methionine (5 mM) and NaN3 (1 mm Table 3 . Gelatinase and stromelysin activities in culture media of rabbit dermal fibroblasts cultured on type IV collagen: a comparison with the percentage lysis of films Cell supematants from an experiment similar to that shown in Table 1 were assayed for gelatinase and stromelysin activity (as described in the Materials and methods section) after 48 h incubation on type IV collagen films. Total-activity values were obtained from assays conducted in the presence of 0.7 mM-APMA. Table 1 ) were run non-reduced on a 7 % polyacrylamide gel with gelatin (0.5 mg/ml) incorporated and zones of lysis were revealed as described in the text. Culture media for the experiment were as follows: lane a, DMEM alone; lanes b and c, DMEM + PMA (10 ng/ml); lanes d and e, DMEM +PMA (10 ng/ml)+ SOD (100 ,sg/ml); lanes f and g, DMEM+SOD (100 ,g/ml); lanes h and i, DMEM + PMA (10 ng/ml) +catalase (25 ,sg/ml); lanesj and k, DMEM +catalase (25 ,g/ml) . The 
Zymogram analysis of cell supernatants
Zones of lysis on gelatin substrate gels (Figs. 2-4) showed that while both gelatinases A (molecular masses determined from zymograms are those of non-reduced proteins; under these conditions progelatinase A has an apparent molecular mass of 66 kDa) and B were present in cell supernatants from PMAtreated cells (Fig. 2, lanes b and c) , only gelatinase A was present in those from unstimulated cells (Fig. 2, lane a) . Gelatinase B from treated cells was all in the form of a broad band of activated enzyme (75-80 kDa) which electrophoresed with the same mobility as APMA-activated gelatinase B (results not shown). Approx. 50 % of gelatinase A from the stimulated cells was in the active 59 kDa form (Fig. 2, lanes b and c) inhibition were analysed on gelatin zymograms (Fig. 3) , conversion of gelatinase A into the lower 59 kDa form and induction of gelatinase B could again be seen in those supernatants where catalase had been removed (Fig. 3, lanes m and n) , during the recovery period. The MMP inhibitor 1,10-phenanthroline (2 mM) abolished zones of lysis on one half of a zymogram analysis of culture supernatants from cells grown on films with or without PMA (Fig. 4, lanes a-d) . Where 1,10-phenanthroline had not been included, bands of lysis were revealed as described previously m n (Fig. 4, lanes e-h) Fig. 4 . Inhibition of gelatin lysis by 1,10-phenanthroline Cell supernatants (5 ,ul) from a type-IV-collagen-film experiment (similar to that shown in Table 1 ) were run non-reduced on an 8 % gelatin substrate gel. Culture media for the experiment were: Lanes a, b, e and f, DMEM; lanes c, d, g and h, DMEM + PMA (10 ng/ml). After SDS removal, by washing twice with 2.5 % Triton X-100, the gel was rinsed in water, cut in half and the two halves incubated at room temperature overnight in: lanes a-d, Ca2+-free Tris/HCl buffer (100 mM-Tris/HCI, pH 7.9)+2 mM-1,10-phenanthroline. Lanes e-h, Tris/HCl buffer (pH 7.9)/30 mM-CaCl2. The gel was stained and destained as described in the Materials and methods section.
appearing at 59 kDa must therefore be due to enzyme which has been naturally activated in the cultures. Where catalase had been included with the cultures (Fig. 2, lanes h and i) there was little conversion of gelatinase A into 59 kDa. There was also a substantial decrease in the total amount of gelatinase B, and what was produced was mostly-in the higher-molecular-mass pro-form. Supernatants from cells incubated with PMA and SOD (100 ,ug/ml) (Fig. 2, lanes d and e) showed no inhibition of gelatinase B induction or gelatinase A activation. When media from a similar experiment to investigate catalase DISCUSSION Our results demonstrate that normal rabbit dermal fibroblasts can be induced by the tumour promoter PMA to degrade type IV collagen and gelatin films. This degradation can be inhibited by TIMP-1, specific antibodies to gelatinase and stromelysin and by the reactive-oxygen-metabolite inhibitor catalase. The inhibitory effects of both TIMP-1 and the specific antibodies demonstrate unequivocally the role of MMPs in this model system of degradation. Garbisa et al. (1980) used a similar model system to compare the degradation of [14C]proline-labelled type IV collagen by highly metastatic tumour cells with non-invasive and normal cells. They demonstrated that only metastatic cells spontaneously degraded the films, probably by the local activation of a type IV collagenase at the cell/substrate interface. The results from our experiments indicate that, at least in this model system, degradation oftype IV collagen or gelatin is accompanied by activation of both gelatinase A and B. Whether one of those two enzymes is more important in this degradative process is unclear, and further experiments using antibodies which are specific for the individual gelatinases may be useful in attempting to answer this question. Gavrilovic et al. (1985) used type I collagen films to demonstrate the role of collagenase in collagen degradation biy tumour cells and the controlling role of TIMP in inhibiting its degradation by chondrocytes and endothelial cells (Gavrilovic et al., 1987) . The rabbit dermal fibroblasts used in these experiments appear to make no detectable levels of TIMP, as assessed by inhibition assays of the cell supernatants, whether unstimulated or stimulated with PMA, and very few positively staining cells were seen in immunolocalization studies. However, exogenously added human recombinant TIMP-l was able to inhibit their degradative behaviour, thus providing further evidence for a role for MMPs. The involvement of plasmin in the MMP activation cascade was demonstrated in a similar model system using osteoblasts (Thomson et al., 1989) . Although our experiments were conducted in serum-free conditions to exclude plasminogen conversion into plasmin, since plasmin itself degrades type IV collagen and gelatin, it is possible that some plasminogen remains cell-bound in the initial stages of the experiments when the cells are attached to the films in serum-containing medium. However, inhibitors of plasmin, such as a.-antiplasmin and aprotinin, as well as antibodies to plasminogen activators, were unable to inhibit degradation of the films, and appeared not to affect the appearance of the lower-molecular-mass forms of gelatinase B seen on gelatin zymograms (results not shown). It is possible that this can be explained by a failure of the antibodies to reach the site of plasminogen activation, which is at its most efficient on the cell surface (Ellis et al., 1991; Manchanda & Schwarz, 1991) . Alternatively it may be explained by the protection from inhibition by both a2-antiplasmin and a2-macroglobu1in afforded
Vol. 288 to cell-bound plasminogen activator demonstrated by Hall et al. (1991) . Thus, in our model system, plasminogen bound to the cell surface and receptor-bound plasminogen activator could still be available for the activation of gelatinase B, via plasmin.
We have been able to demonstrate that plasmin, generated by plasminogen/streptokinase, is capable ofactivating progelatinase B in vitro, although high doses of plasminogen are required (Murphy et al., 1992b) . Because relatively high doses are required, it seems unlikely that sufficient plasmin is available in this model system to activate all the progelatinase B which is present and suggests that an alternative method of activation may also be involved. It has not been possible to show a similar activation by plasmin of progelatinase A in vitro and we must therefore assume that its activation in these experiments is by a plasminindependent mechanism. Brown et al. (1990) demonstrated a similar phorbol-ester-inducible activation of progelatinase A in WI-38 and HT1080 cells, which was not inhibited by serineproteinase inhibitors and therefore probably not plasmin-dependent. Our previous work demonstrated that human foreskin fibroblasts stimulated by concanavalin A activate progelatinase A, but do not activate progelatinase B (Ward et al., 1991b) , indicating a progelatinase A-specific mechanism.
Synthesis and secretion of stromelysin by rabbit dermal fibroblasts was increased with PMA treatment, but little of the enzyme detected in the media was in the active form, and levels were low compared with those of gelatinase. Plasmin readily activates prostromelysin, and we have recently demonstrated that active stromelysin can also activate progelatinase B (Murphy et al., 1992b) . Nagase et al. (1991) also described a stepwise activation of gelatinase B involving stromelysin. It is therefore likely that both plasmin and stromelysin contribute to the activation of gelatinase B (but not gelatinase A) in this system and both themselves degrade type IV collagen and gelatin. This can be compared with our previous observations that stromelysin potentiates trypsin or plasmin activation of procollagenase and that stromelysin is essential for cellular degradation of collagen by collagenase (Murphy et al., 1992 a) .
The inhibition of degradation by catalase is difficult to interpret. Oxygen free radicals have been implicated in a variety of pathological disorders, including cancer and inflammatory diseases and, in association with proteolytic enzymes, are involved in cartilage degradation by acting on collagen, hyaluronic acid and proteoglycan (Greenwald & Moy, 1980; Monboisse et al., 1984; Bates et al., 1985) . Tiku et al. (1990) demonstrated the production of hydrogen peroxide by rabbit articular chondrocytes, which could be enhanced by cytokines, and postulated that the reactive oxygen intermediates may have a role in the regulation of procollagenase activation. Zymogram analysis of the cell supernatants from our experiments revealed that PMA significantly induced secretion and activation of progelatinase B and activation of progelatinase A. Catalase appeared to inhibit these induction and activation processes. Immunolocalization studies (results not shown) on rabbit dermal fibroblasts treated with either PMA or PMA and catalase, using specific antibodies to both gelatinases and to TIMP-1, confirmed the results seen by enzyme and inhibition assays and by zymogram analysis of the cell supernatants; i.e. catalase inhibition of PMA induction of gelatinase B and negligible TIMP-1 production. We also found that catalase has an inhibitory effect on the cell-shape change seen when PMA alone is added to the cultures. These results imply that catalase may exert its inhibitory effect by means of preventing the cells' response to PMA rather than by inhibiting a gelatinase-activating mechanism involving free radicals.
The expression ofboth gelatinases A and B has been correlated in several model systems with acquisition of the malignant phenotype and the ability of cells to invade extracellular matrices (Garbisa et al., 1987; Collier et al., 1988; Ostrowski et al., 1988; Bonfil et al., 1989 
